Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Mov Disord. 2011 Dec;26(14):2567-71. doi: 10.1002/mds.23955. Epub 2011 Sep 27.
The aim of this work was to investigate the prevalence of camptocormia and the clinical characteristics of patients with camptocormia in a large population of PD patients.
Although camptocormia has been recognized as a prominent phenomenon in PD, the previous epidemiological reports were limited, especially in terms of sample size.
We evaluated 531 PD patients (disease duration: 7.0 ± 5.5 years, mean ± standard deviation). We examined their clinical features and the prevalence of camptocormia.
Camptocormia was detected in 22 patients (4.1%) and found in patients who were older and had more severe motor symptoms and a higher levodopa (L-dopa) dose (P < 0.05), compared to the patients without camptocormia. Patients with camptocormia showed significantly higher frequencies of autonomic symptoms, such as constipation and urinary incontinence (P < 0.05).
Camptocormia is uncommon in PD and is associated with disease severity, higher L-dopa dose and higher frequencies of autonomic symptoms.
本研究旨在调查大样本帕金森病(PD)患者中脊柱前屈畸形的患病率及其临床特征。
尽管脊柱前屈畸形已被认为是 PD 的一个突出表现,但之前的流行病学报道数量有限,尤其是在样本量方面。
我们评估了 531 名 PD 患者(病程:7.0±5.5 年,平均值±标准差)。我们检查了他们的临床特征和脊柱前屈畸形的患病率。
22 名患者(4.1%)出现脊柱前屈畸形,与无脊柱前屈畸形的患者相比,这些患者年龄更大,运动症状更严重,左旋多巴(L-dopa)剂量更高(P<0.05)。脊柱前屈畸形患者更常出现自主神经症状,如便秘和尿失禁(P<0.05)。
PD 中脊柱前屈畸形并不常见,与疾病严重程度、L-dopa 剂量更高和更高频率的自主神经症状有关。